## Abstract We determined mortality rates and predictors of survival in 238 consecutive patients with Parkinson's disease (PD) with symptom onset between 1974 and 1984. All patients were regularly followed at the Movement Disorder Clinic (Department of Neurology at the Innsbruck Medical University)
The use of L-DOPA in Parkinson's disease: a 20 year follow-up
✍ Scribed by André Barbeau
- Book ID
- 119110700
- Publisher
- Elsevier Science
- Year
- 1981
- Tongue
- English
- Weight
- 474 KB
- Volume
- 2
- Category
- Article
- ISSN
- 0165-6147
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Fatigue affects about 50% of Parkinson's disease (PD) patients and is frequently one of its most disabling aspects. It does not correlate with disease severity or duration but does correlate with depression. Fatigue and depression are distinct symptoms and fatigue often fails to respond
## Abstract Thirty‐one drug‐naive patients with Parkinson's disease (PD) underwent 6‐[^18^F]fluoro‐L‐dopa (F‐dopa) positron emission tomography (PET) scan at the time of the diagnosis (baseline) and 2 years later in order to investigate F‐dopa uptake in striatal and extrastriatal regions during the